Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 8/20 | 0.50 |
| ▸ | NPC1 | O15118 | 7/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.50 |
| ▸ | RELA | Q04206 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | CASP3 | P42574 | 3/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18359200 | 0.78 | NPC1 (0.68) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL2968032 | 0.77 | PLAU (0.58) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3102294 | 0.76 | PLAU (0.57) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL16697633 | 0.74 | ALDH1A1 (0.50) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL6328340 | 0.74 | PRKCI (0.58) | RAB9ANPC1MAPT | |
| SCHEMBL5787334 | 0.73 | ALDH1A1 (0.69) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL29723925 | 0.73 | ALDH1A1 (0.53) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL4354695 | 0.72 | ALDH1A1 (0.62) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL2601929 | 0.72 | ALDH1A1 (0.74) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL4824941 | 0.72 | SRD5A2 (0.82) | ALDH1A1MAPK1RAB9ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350903-B | Anti-corrosion fireproof sandwich structure coating for nuclear island and preparation method and application thereof | 大厂金隅涂料有限责任公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119350903-A | Anti-corrosion fireproof sandwich structure coating for nuclear island and preparation method and application thereof | 大厂金隅涂料有限责任公司 | 2025-01-24 | — | — | CN | claimed |
| US-11932632-B1 | N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5 carboximidamide as an antimicrobial compound | King Faisal University (SA) | 2024-03-19 | — | — | US | claimed |
| US-11926621-B1 | N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5-carboximidamide as an antimicrobial compound | King Faisal University (SA) | 2024-03-12 | — | — | US | claimed |
| EP-3634403-B1 | PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA | MAX PLANCK GESELLSCHAFT (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| CN-119350903-B | Anti-corrosion fireproof sandwich structure coating for nuclear island and preparation method and application thereof | 大厂金隅涂料有限责任公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119350903-A | Anti-corrosion fireproof sandwich structure coating for nuclear island and preparation method and application thereof | 大厂金隅涂料有限责任公司 | 2025-01-24 | — | — | CN | disclosed |
| US-11932632-B1 | N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5 carboximidamide as an antimicrobial compound | King Faisal University (SA) | 2024-03-19 | — | — | US | disclosed |
| US-11926621-B1 | N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5-carboximidamide as an antimicrobial compound | King Faisal University (SA) | 2024-03-12 | — | — | US | disclosed |
| US-11180518-B2 | Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-11-23 | — | — | US | disclosed |
| US-20200165279-A1 | PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-05-28 | — | — | US | disclosed |
| US-20100173933-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2010-07-08 | — | — | US | disclosed |
| EP-1996180-A1 | ANTIBACTERIAL AGENTS | Prolysis Limited (GB) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007107758-A1 | ANTIBACTERIAL AGENTS | PROLYSIS LTD (GB) | 2007-09-27 | — | — | WO | disclosed |
| US-6924284-B2 | PARP inhibitors | ICOS CORPORATION (US) | 2005-08-02 | — | — | US | disclosed |
| EP-1373264-B1 | 3-HETEROCYCLYLPROPANOHYDROXAMIC ACID AS PROCOLLAGEN C-PROTEINASE INHIBITORS | PFIZER LTD (GB) | 2004-12-22 | — | — | EP | disclosed |
| US-6821972-B2 | ANTISCARRING AGENTS; WOUND HEALING AGENTS; ENZYME INHIBITORS | PFIZER INC. | 2004-11-23 | — | — | US | disclosed |
| US-20040087588-A1 | Parp inhibitors | ICOS CORPORATION | 2004-05-06 | — | — | US | disclosed |
| US-20030069291-A1 | 3-heterocyclylpropanohydroxamic acid PCP inhibitors | PFIZER INC. | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11926621-B1 | N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5-carboximidamide as an antimicrobial compound | NOD1, AADAC, DAO | ALDH1A1 913/4885MAPK1 2398/4885RAB9A 3550/4885 |
| US-20040087588-A1 | Parp inhibitors | PARP1, PARP2, PARP11 | ALDH1A1 338/4885MAPK1 922/4885RAB9A 4452/4885 |
| US-20200165279-A1 | PHENYL-HETEROCYCLE-PHENYL DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA | TYR, MITF, VHL | ALDH1A1 32/4885MAPK1 1540/4885RAB9A 2195/4885 |
| US-11180518-B2 | Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma | TYR, MITF, VHL | ALDH1A1 32/4885MAPK1 1540/4885RAB9A 2195/4885 |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | ALK, ROS1, NOX1 | ALDH1A1 800/4885MAPK1 419/4885RAB9A 2799/4885 |
| US-20100173933-A1 | ANTIBACTERIAL AGENTS | ALK, ROS1, NOX1 | ALDH1A1 800/4885MAPK1 419/4885RAB9A 2799/4885 |
| US-11932632-B1 | N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5 carboximidamide as an antimicrobial compound | NOD1, AADAC, DAO | ALDH1A1 910/4885MAPK1 1867/4885RAB9A 3927/4885 |
| US-20030069291-A1 | 3-heterocyclylpropanohydroxamic acid PCP inhibitors | PAH, CYP2F1, CYP7A1 | ALDH1A1 376/4885MAPK1 1221/4885RAB9A 1744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.